179 related articles for article (PubMed ID: 16541208)
1. Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
Hänggi D; Steiger HJ
Acta Neurochir (Wien); 2006 Jun; 148(6):605-13; discussion 613. PubMed ID: 16541208
[TBL] [Abstract][Full Text] [Related]
2. The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm.
Lin CL; Su YF; Dumont AS; Shih HC; Lieu AS; Howng SL; Lee KS; Kwan AL
Acta Neurochir (Wien); 2006 Aug; 148(8):873-9; discussion 879. PubMed ID: 16791438
[TBL] [Abstract][Full Text] [Related]
3. Sodium nitrite as a therapeutic agent for central nervous system diseases.
Pluta RM; Oldfield EH
Surg Neurol; 2006 Jul; 66(1):5-7; discussion 8-10. PubMed ID: 16793425
[No Abstract] [Full Text] [Related]
4. Nitric oxide related pathophysiological changes following subarachnoid haemorrhage.
Sabri M; Ai J; Macdonald RL
Acta Neurochir Suppl; 2011; 110(Pt 1):105-9. PubMed ID: 21116924
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
Pluta RM
Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036
[TBL] [Abstract][Full Text] [Related]
6. The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage.
Fathi AR; Bakhtian KD; Pluta RM
Acta Neurochir Suppl; 2011; 110(Pt 1):93-7. PubMed ID: 21116922
[TBL] [Abstract][Full Text] [Related]
7. Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits.
Neuschmelting V; Marbacher S; Fathi AR; Jakob SM; Fandino J
Acta Neurochir (Wien); 2009 Jul; 151(7):795-801; discussion 801-2. PubMed ID: 19415172
[TBL] [Abstract][Full Text] [Related]
8. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
Pluta RM
Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and cerebral vasospasm after subarachnoid hemorrhage.
Pradilla G; Chaichana KL; Hoang S; Huang J; Tamargo RJ
Neurosurg Clin N Am; 2010 Apr; 21(2):365-79. PubMed ID: 20380976
[TBL] [Abstract][Full Text] [Related]
10. The role of constitutive and inducible nitric oxide synthase in the human brain after subarachnoid hemorrhage.
Berra LV; Carcereri De Prati A; Suzuki H; Pasqualin A
J Neurosurg Sci; 2007 Mar; 51(1):1-9. PubMed ID: 17369785
[TBL] [Abstract][Full Text] [Related]
11. Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage.
Topcuoglu MA; Singhal AB
Expert Opin Drug Saf; 2006 Jan; 5(1):57-65. PubMed ID: 16370956
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.
Recinos PF; Pradilla G; Thai QA; Perez M; Hdeib AM; Tamargo RJ
Surg Neurol; 2006 Nov; 66(5):463-9; discussion 469. PubMed ID: 17084186
[TBL] [Abstract][Full Text] [Related]
13. Advances in experimental subarachnoid hemorrhage.
Zhou Y; Martin RD; Zhang JH
Acta Neurochir Suppl; 2011; 110(Pt 1):15-21. PubMed ID: 21116908
[TBL] [Abstract][Full Text] [Related]
14. Subarachnoid haemorrhage: what happens to the cerebral arteries?
Sobey CG; Faraci FM
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):867-76. PubMed ID: 9807657
[TBL] [Abstract][Full Text] [Related]
15. [Perspectives of pharmacological correction of nitroxidergic vasorelaxation in subarachnoidal hemorrhage].
Karpiuk VB; Shubich MG
Zh Vopr Neirokhir Im N N Burdenko; 2002; (2):56-61. PubMed ID: 12214511
[TBL] [Abstract][Full Text] [Related]
16. Genetic modification of cerebral arterial wall: implications for prevention and treatment of cerebral vasospasm.
Vijay A; Santhanam R; Katusic ZS
Neurol Res; 2006 Oct; 28(7):759-68. PubMed ID: 17164039
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
Suhardja A
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
Pannu R; Singh I
Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine inhibition of iNOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in rabbits via restoration of dysfunctional endothelial cells.
Zheng B; Zheng T; Wang L; Chen X; Shi C; Zhao S
J Neurol Sci; 2010 Aug; 295(1-2):97-103. PubMed ID: 20537662
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan.
Sabri M; Ai J; Macdonald RL
Stroke; 2011 May; 42(5):1454-60. PubMed ID: 21454820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
